Session 304
Optimizing Alliance Management Support Models

In an industry with a proliferation of development and vendor relationships, as well as more cross-sector partnerships within the healthcare ecosystem, defining the criteria for alliance management support is critical to the success of a business—the line of what is supported or not gets blurry at times. In this lively, interactive session, Amgen alliance management will walk through their current support model, how it was determined, and challenges faced during the iterations of this initiative. Not only does a central alliance management function need a strong understanding of cross-company partnerships to determine the criteria for a support model, they need answers to a number of challenging cross-functional questions and the pros and cons of blurring the line.

Bring your questions and be prepared to share your own experiences as this session dives into this challenging and relevant topic. To frame the discussion, here's some food for thought:


Tracy Blois, Phd
Director, Alliance Management Business Development

Tracy has spent more than a decade working in biotechnology and presently works as a director in Alliance Management with Amgen's Business Development group. In this role, she has managed a diverse set of early and late stage partnerships across Amgen's portfolio. Previously, as the head of Business Development's Operations group, she led a team to support the successful identification, evaluation, and execution of licensing and equity collaborations across the company. Tracy brings additional past experience in quality control, technology transfer, and biochemistry research.Tracy is an active member of the STEM outreach community, serving as a mentor with Amgen's mentoring program and as a past president of the local Association for Women in Science (AWIS) chapter.Tracy earned a Ph.D. in Biochemistry and Molecular Biology from UCLA and a BA in Biochemistry from the University of San Diego.

Jessica Hayden
Director, Alliance Management Business Development

Jessica currently leads the Early-Stage Partnership team within the Alliance Management function at Amgen. She brings significant cross-functional experience to the role, with nearly 20 years in the pharmaceutical and biotechnology industry. Jessica's career has included leadership roles across Marketing, Program and Portfolio Management. In each capacity, she has had the opportunity to collaborate on co-development programs with external partners. As Global Program Manager (GPM) for multiple Inflammation pipeline assets at Amgen, she made significant contributions to the therapeutic area strategy, and stewarded governance portal decisions.

Prior to joining Amgen, Jessica led global strategic marketing of inflammation pipeline programs at Janssen, and held successive portfolio management and strategy roles at Janssen and Boehringer Ingelheim. Jessica received her Bachelor of Science degree in Biochemistry and Cell Biology from the University of California, San Diego, and her MBA from the College of William and Mary in Virginia.